Announcement

Collapse
No announcement yet.

Procedure for spotted fever group Rickettsia isolation from limited clinical blood specimens - PLOS

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Procedure for spotted fever group Rickettsia isolation from limited clinical blood specimens - PLOS

    Published: October 14, 2022

    Author summary Spotted fever group Rickettsia (SFGR) are Gram-negative intracellular bacteria that during early onset localize in blood vessel endothelium before disseminating in the bloodstream and lymph via lymphocytes and other non-endothelial cells. Morbidity and mortality vary by species, with fatality rates up to 37% of PCR-positive cases in Mexico (Rickettsia rickettsii), with outcomes dependent on patient access to healthcare. SFGR disproportionately affects those in impoverished communities worldwide, and presentation is often with nonspecific symptoms, making early diagnosis difficult. Advances in acute laboratory diagnostics are critical to improve timely confirmatory diagnosis and our understanding of disease progression. Clinical culture and isolation methodologies for SFGR are largely unchanged since the development of the shell vial technique in 1989. We validated an isolation method that utilizes small volumes of acute clinical sample and minimal culture manipulation by first determining best practices for sample preparation, sampling methodology, and timing of sampling. This optimization resulted in detection of low copy number inoculums as early as 2 days in both cellular monolayer and culture supernatant samples. Initial testing was done across multiple SFGRs to demonstrate that species with varying virulence can be isolated using similar parameters. This simplified, efficient method for SFGR isolation from clinical samples has the potential to compliment and improve diagnostic testing, reflex testing, isolate characterization, and research studies.


    Marah E. Condit, Emma Jones, Brad J. Biggerstaff, Cecilia Y. Kato

    Abstract

    Background
    Current isolation techniques for spotted fever group Rickettsia from clinical samples are laborious and are limited to tissue, blood and blood derivatives with volumes ideally greater than 1 mL. We validated the use of simplified methodologies for spotted fever group Rickettsia culture isolation that overcome sample volume limitations and provide utility in clinical diagnostics and research studies.

    Methodology/Principal findings
    A modified cell culture method is evaluated for the isolation of Rickettsia ssp. from human diagnostic samples. Culture sampling method, culture platform, and growth phase analysis were evaluated to determine best practices for optimal culture isolation conditions. Rickettsial isolates (R. conorii, R. rickettsii, and R. parkeri) were grown in Vero E6 cells over a course of 5 to 7 days at low inoculum treatments (~40 bacterial copies) to standardize the sampling strategy at a copy number reflective of the bacteremia in acute diagnostic samples. This methodology was verified using small volumes (50 μL) of 25 unprocessed clinical whole blood, plasma, and serum samples from acute samples of patients suspected of having Rocky Mountain Spotted Fever, of which 10 were previously confirmed positive via the PanR8 qPCR assay, 13 had no detectable Rickettsia DNA by the PanR8 qPCR assay, and 2 were not previously tested; these samples resulted in the cultivation of 7 new R. rickettsii isolates.

    Conclusions/Significance
    We observed that rickettsial isolate growth in culture is reproducibly identified by real-time PCR testing of culture media within 72 hours after inoculation. Additionally, specimen sedimentation prior to isolation to remove red blood cells was found to decrease the amount of total organism available in the inoculum. A small volume culture method was established focusing on comparative qPCR detection rather than bacterial visualization, taking significantly shorter time to detect, and requiring less manipulation compared to traditional clinical isolate culture methods.

    Author summary Spotted fever group Rickettsia (SFGR) are Gram-negative intracellular bacteria that during early onset localize in blood vessel endothelium before disseminating in the bloodstream and lymph via lymphocytes and other non-endothelial cells. Morbidity and mortality vary by species, with fatality rates up to 37% of PCR-positive cases in Mexico (Rickettsia rickettsii), with outcomes dependent on patient access to healthcare. SFGR disproportionately affects those in impoverished communities worldwide, and presentation is often with nonspecific symptoms, making early diagnosis difficult. Advances in acute laboratory diagnostics are critical to improve timely confirmatory diagnosis and our understanding of disease progression. Clinical culture and isolation methodologies for SFGR are largely unchanged since the development of the shell vial technique in 1989. We validated an isolation method that utilizes small volumes of acute clinical sample and minimal culture manipulation by first determining best practices for sample preparation, sampling methodology, and timing of sampling. This optimization resulted in detection of low copy number inoculums as early as 2 days in both cellular monolayer and culture supernatant samples. Initial testing was done across multiple SFGRs to demonstrate that species with varying virulence can be isolated using similar parameters. This simplified, efficient method for SFGR isolation from clinical samples has the potential to compliment and improve diagnostic testing, reflex testing, isolate characterization, and research studies.

Working...
X